Knowing the risks related to the non-compliance of your medical devices enables you to build an effective business model. In order to reduce the time to market of your devices and the risks linked to non-compliance, you can already adapt to the new regulations. Find out more about the challenges of compliance here.
Regulation 2017/745 on medical devices will enter into force on 26th May 2021. After having seen its first deadline postponed by one year due to the Covid-19 pandemic, it will, from this date, impose new obligations on the various economic operators in the medical devices industry. Here is a quick summary of the key points to remember.
With Brexit and the entry into force of UK REACH, the UK counterpart of the European REACH regulation, many companies will be considered as being based in a third country. For this reason, downstream users may see their role changed. We look back for you on these changes and how best to anticipate them, for you or your customers.
The UK REACH regulation came into force on 1st January 2021, at the end of the transition period which followed Brexit. We have taken a look at the various deadlines that follow this first step for you.
Brexit has had an impact on many sectors. The chemical industry in particular is impacted by the introduction of the UK REACH regulation, the British counterpart of EU REACH, at the end of the transition period on 1st January 2021.